Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cope

Showing results (41-50 of 187) with videos related to

Pageof 19
Sort By:
Proteomics|May 12, 2005
Two-stage affinity purification for inducibly phosphorylated membrane proteinsMatthew J Peirce, Shajna Begum, Jeremy Saklatvala, et al.
The Journal of Rheumatology|May 3, 2019
Placebo Response in Rheumatoid Arthritis Clinical TrialsKatie Bechman, Mark Yates, Sam Norton, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulinM Congia, S Patel, A P Cope, et al.
Molecular & Cellular Proteomics : MCP|October 24, 2003
Expression profiling of lymphocyte plasma membrane proteinsMatthew J Peirce, Robin Wait, Shajna Begum, et al.
Journal of Biophotonics|February 10, 2015
Topographic prominence as a method for cluster identification in single-molecule localisation dataJuliette Griffié, Lies Boelen, Garth Burn, et al.
Frontiers in Immunology|February 13, 2020
PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody LymphodepletionJohanna A Knipper, David Wright, Andrew P Cope, et al.
Annals of the Rheumatic Diseases|June 1, 1992
Possible induction of systemic lupus erythematosus by human parvovirusA P Cope, A Jones, M Brozovic, et al.
Rheumatology (Oxford, England)|September 15, 2005
Planning your research trainingA P Cope, F M Brennan, J S Hill Gaston, et al.
FEBS Letters|April 26, 2011
Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?Garth L Burn, Lena Svensson, Cristina Sanchez-Blanco, et al.
BMC Rheumatology|December 9, 2020
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritisKatie Bechman, Anthony Dalrymple, Charles Southey-Bassols, et al.
Pageof 19

Showing results (41-50 of 187) with videos related to

Sort By:
Pageof 19
Proteomics|May 12, 2005
Two-stage affinity purification for inducibly phosphorylated membrane proteinsMatthew J Peirce, Shajna Begum, Jeremy Saklatvala, et al.
The Journal of Rheumatology|May 3, 2019
Placebo Response in Rheumatoid Arthritis Clinical TrialsKatie Bechman, Mark Yates, Sam Norton, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulinM Congia, S Patel, A P Cope, et al.
Molecular & Cellular Proteomics : MCP|October 24, 2003
Expression profiling of lymphocyte plasma membrane proteinsMatthew J Peirce, Robin Wait, Shajna Begum, et al.
Journal of Biophotonics|February 10, 2015
Topographic prominence as a method for cluster identification in single-molecule localisation dataJuliette Griffié, Lies Boelen, Garth Burn, et al.
Frontiers in Immunology|February 13, 2020
PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody LymphodepletionJohanna A Knipper, David Wright, Andrew P Cope, et al.
Annals of the Rheumatic Diseases|June 1, 1992
Possible induction of systemic lupus erythematosus by human parvovirusA P Cope, A Jones, M Brozovic, et al.
Rheumatology (Oxford, England)|September 15, 2005
Planning your research trainingA P Cope, F M Brennan, J S Hill Gaston, et al.
FEBS Letters|April 26, 2011
Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?Garth L Burn, Lena Svensson, Cristina Sanchez-Blanco, et al.
BMC Rheumatology|December 9, 2020
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritisKatie Bechman, Anthony Dalrymple, Charles Southey-Bassols, et al.
Pageof 19